DOSSIER · 13F Holders · Q1 2026Healthcare · Biological Products, (No Diagnostic Substances)
RVMD
REVOLUTION MEDICINES INC
592 institutions still hold REVOLUTION MEDICINES INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 76155X100·Biological Products, (No Diagnostic Substances)·592 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
592 institutions reported RVMD in Q1 2026. FARALLON CAPITAL MANAGEMENT LLC leads at 11.2% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 30
572 more holders available. Log in →